CVC sells further shares in Evonik ahead of IPO
CVC and Rag Foundation have sold a further 4.6% stake in German chemicals business Evonik, reducing their stakes by around 6% each in total, ahead of a renewed attempt at listing the business.
The investors announced on Monday that they have sold 4.6% of Evonik to Singapore's sovereign wealth fund Temasek. The value of the sale was said to be around €600m, which would lift the company's enterprise value to around €14bn. The investors confirmed that this concluded their private placement ahead of the IPO.
Evonik already prepared for an IPO last year and the year before, but cancelled both times due to market volatility. The company's two owners, CVC and the Rag Foundation, sold parts of their stakes in Evonik to institutional investors last month and announced renewed preparations for an IPO this year.
The flotation of the business is intended to secure income to cover the liabilities associated with the ending of subsidised coal mining in Germany in 2018. Evonik had revenues of €14.5bn in 2011, generating an EBITDA of €2.8bn.
CVC employed a similar strategy of private placement prior to the listing of its portfolio company Formula One Group last year.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








